Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.

A group of researchers have created four novel laboratory-developed tests that can distinguish between and subclassify atopic dermatitis and psoriasis molecular markers. Image: Adobe Stock.

Among 25 different measures of adiposity, abdominal fat was significantly associated with a risk for psoriasis. Among 25 ...

including lipids, metabolites, and peptides; clinical markers ... to assist with PsA diagnosis (iPROLEPSIS), to distinguish subtypes of atopic dermatitis and psoriasis using biomarkers (BIOMAP ...

For patients with psoriasis receiving biologic therapy, residual inflammation (RI), defined as increased inflammatory markers ...